Drug recall D-0774-2022

Class II Terminated reported Apr 27, 2022

Product

Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60

Reason for recall

Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

Lots and codes

Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023

Recall details

Recalling firm
Mylan Pharmaceuticals Inc, Morgantown, WV
Quantity
33,893 vials
Distribution
Nationwide in the USA
Type
Voluntary: Firm initiated
Recall initiated
April 7, 2022
Terminated
May 23, 2023

Related products